
Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Transfusion-associated graft versus host disease epidemiology and demographics
Introduction
Please help WikiDoc by adding more content here. It’s easy! Click here to learn about editing.
Overview
Overview
Epidemiology and Demographics
Epidemiology and Demographics
The incidence in immunocompromised patients receiving blood transfusions is estimated to be 0.1 – 1.0%, mortality around 80 – 90%. Mortality is higher in TA-GvHD than in GvHD associated with bone marrow transplantation, where the engrafted lymphoid cells in the bone marrow are of donor origin; therefore, the immune reaction is not directed against them.
References
References
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
